STOCK TITAN

NovaBay Pharmaceuticals to Hold Third Quarter 2023 Conference Call on November 9, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023. An investment community conference call will be held on the same day at 4:30 p.m. Eastern time. Participants can pre-register for the conference call to receive a conference passcode and unique PIN. The live webcast of the conference call will be available on the Company website. A replay of the call will be available afterwards.
Positive
  • None.
Negative
  • None.

EMERYVILLE, Calif.--(BUSINESS WIRE)-- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and nine months ended September 30, 2023 after market close on Thursday, November 9, 2023 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time.

Date/Time:

Thursday, November 9, 4:30 p.m. ET / 1:30 p.m. PT

 

 

Pre-Registration:

Participants can pre-register for the conference call here:

 

 

 

Callers who pre-register will be given a conference passcode and unique PIN to gain immediate access to the call and bypass the live operator. Participants may pre-register at any time, including up to and after the call start time.

 

 

Dial In:

Those who choose not to pre-register can access the live conference call by dialing the following and requesting the NovaBay Pharmaceuticals call:

 

833-816-1121 from within the U.S.

 

412-317-1862 from outside the U.S.

The live webcast of the conference call also will be available on the Events section of the Company website. A replay of the call will be available beginning two hours after its completion through November 30, 2023 by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada or 412-317-0088 from outside the U.S., and entering conference ID 7329052. The webcast will also be archived here.

About NovaBay Pharmaceuticals, Inc:

NovaBay Pharmaceuticals, Inc. develops and sells scientifically created and clinically proven eyecare and skincare products. NovaBay’s leading product, Avenova® Antimicrobial Lid & Lash Solution, is often prescribed by eyecare professionals for blepharitis and dry-eye disease and is also available directly to eyecare consumers through online distribution channels such as Amazon. DERMAdoctor® offers more than 30 dermatologist-developed skincare products through the DERMAdoctor website, well-known traditional and digital beauty retailers, and international distributors. NovaBay also manufactures and sells effective, yet gentle and non-irritating wound care products. The PhaseOne® brand is distributed through commercial partners in the U.S. for professional use only, and the NeutroPhase® brand is distributed in China by Pioneer Pharma (Hong Kong) Company Ltd.

Socialize and Stay Informed on NovaBays Progress
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Visit NovaBay’s Website

Avenova Purchasing Information
For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com
Avenova.com

DERMAdoctor Purchasing Information
For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com

NovaBay

Justin Hall

Chief Executive Officer and General Counsel

510-899-8800

jhall@novabay.com

Investors

LHA Investor Relations

Jody Cain

310-691-7100

jcain@lhai.com

Source: NovaBay Pharmaceuticals, Inc.

FAQ

When will NovaBay Pharmaceuticals release its financial results for the three and nine months ended September 30, 2023?

NovaBay Pharmaceuticals will release its financial results on Thursday, November 9, 2023.

What time will the investment community conference call begin on November 9, 2023?

The conference call will begin at 4:30 p.m. Eastern time on November 9, 2023.

How can participants pre-register for the conference call?

Participants can pre-register for the conference call on the Company website.

How can participants access the live conference call without pre-registering?

Participants can access the live conference call by dialing 833-816-1121 from within the U.S. or 412-317-1862 from outside the U.S. and requesting the NovaBay Pharmaceuticals call.

Will there be a replay of the conference call?

Yes, a replay of the conference call will be available by dialing 877-344-7529 from within the U.S., 855-669-9658 from Canada, or 412-317-0088 from outside the U.S. and entering conference ID 7329052.

NovaBay Pharmaceuticals, Inc.

NYSE:NBY

NBY Rankings

NBY Latest News

NBY Stock Data

2.51M
4.88M
0.02%
2.58%
3.83%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
EMERYVILLE